Olink

Olink®
Part of Thermo Fisher Scientific

Filters

PublicationDisease areaApplication areaSample typeProducts

International Journal of Molecular Sciences, 2026
Serum Calprotectin in Hospitalized Patients with COVID-19 in Relation to High-Dimensional Serum Proteomic Patterns

Parke ?., Strunz B., Chen P. et al.

Olink Explore 3072/384Immunological & Inflammatory DiseasesInfectious DiseasesPathophysiologySerum

Biomedicine & Pharmacotherapy, 2026
Differential effects of the anti-obesity drug tirzepatide on adipose tissues: Brown fat as a key target

Mestres-Arenas A., Quesada-López T., Blasco-Roset A. et al.

Olink Target 96 MouseMetabolic DiseasesPathophysiologyMouse Plasma

Vaccine, 2026
The effect of BCG vaccination on systemic inflammation in neonates

Koeken V., Nissen T., Birk N. et al.

Olink Target 96Immunological & Inflammatory DiseasesInfectious DiseasesPediatricsPathophysiologyPlasma

Maturitas, 2026
Novel proteomic subtypes of frailty with distinct molecular patterns and prognosis

Xu Z., Wang C., Wang J. et al.

Olink Explore 3072/384AgingPatient StratificationPlasma

Journal of Extracellular Vesicles, 2026
Profiling of Extracellular Vesicles of Non‐Small Cell Lung Cancer Reveals Proteins Associated With Osimertinib Resistance

Cáceres‐Verschae A., Hååg P., Joelsson S. et al.

Olink Target 96OncologyPathophysiologyEV Lysate

PLOS Genetics, 2026
Shared latent genetic liability across fibromyalgia and psychiatric traits: Novel insights from genomic structural equation modeling

Lin L., Li Y., Ji F. et al.

Olink Explore 3072/384NeurologyPathophysiologyPlasma

Medicine, 2026
Osteochondrosis and osteomalacia are distinguished by inflammatory factors and metabolites

Chen J., Liu Y., Chen J. et al.

Olink Target 96OrthopedicsPathophysiologyPatient StratificationPlasma

Cancer, 2026
T‐cell receptor–like chimeric antigen receptor T cells targeting mesothelin: A first‐in‐human dose‐escalation trial for platinum‐resistant advanced ovarian cancer

Shan Y., Ding B., Ji F. et al.

Olink Target 96OncologyImmunotherapyPathophysiologyPlasma

Cytotherapy, 2026
Comparative Profiling of ASC Products Following Harvest with DisoNNex and TrypLE

Johansen E., Bangsgaard S., Lethager L. et al.

Olink Target 96Wider Proteomics StudiesTechnical EvaluationCell Lysate

Medicina, 2026
Explorative Insights into Local Immune Response to BK Virus—A Cross-Sectional Study in Urine Samples Between Transplant Recipients and Non-Immunocompromised Hosts

Michnowska A., Wojciuk B., Reus P. et al.

Olink Target 96Infectious DiseasesNephrologyPathophysiologyUrine

Nature Genetics, 2026
Aberrant cellular communities underlying disease heterogeneity in chronic obstructive pulmonary disease

Zhang Y., Wei H., Nouws J. et al.

Olink Explore HTRespiratory DiseasesPathophysiologyPlasma

International Journal of Surgery, 2026
Multi-omics analysis identifies TBCB as a therapeutic target in sepsis-induced liver injury

Ma X., Peng Z., Lei K. et al.

Olink Explore 3072/384Immunological & Inflammatory DiseasesHepatologyPathophysiologyPlasma

Nature Communications, 2026
Cross-ancestry comparison of aptamer and antibody protein measures

Nicholas J., Katz D., Tahir U. et al.

Olink Explore 3072/384Wider Proteomics StudiesTechnology EvaluationPlasma

Nature Communications, 2026
Longitudinal plasma proteomic signatures of elite and viremic spontaneous HIV controllers

Vadaq N., Groenendijk A., dos Santos J. et al.

Olink Explore 3072/384Infectious DiseasesPathophysiologyPatient StratificationPlasma

GigaScience, 2026
High-definition likelihood inference of genetic colocalization reveals protein biomarkers for human complex diseases

Li Y., Zhai R., Yang Z. et al.

Olink Explore 3072/384Technical StudiesData SciencePlasma

American Journal of Respiratory and Critical Care Medicine, 2026
Molecular endotypes predict differential response to immunosuppressant therapy in non-IPF interstitial lung disease

Maddali M., Pugashetti J., Pienkos S. et al.

Olink Explore 3072/384Respiratory DiseasesPatient StratificationPlasma

Diabetologia, 2026
Blood DNA methylation markers are associated with diabetic kidney disease progression in type 1 diabetes

Syreeni A., Dahlström E., Smyth L. et al.

Olink Explore HTMetabolic DiseasesNephrologyPathophysiologyPlasma

Kidney International Reports, 2026
Dulaglutide Effect on Proteins Associated With CKD Progression

McFarlin B., Tye S., Satake E. et al.

Olink FlexMetabolic DiseasesNephrologyPathophysiologyPlasma

Investigative Ophthalmology & Visual Science, 2026
Olink Proteomic Profiling of Vitreous Humor and Plasma From Proliferative Diabetic Retinopathy Patients Identifies a Novel Inflammatory Molecular Endotype

Lv K., Peng J., Wang H. et al.

Olink Target 96Metabolic DiseasesOphthalmologyPatient StratificationPlasmaVitreous

Kidney International, 2026
Sodium glucose transporter 2 inhibition maintains kidney antibacterial response by decreasing complement C1q

Sendtner G., Miranda J., Naumann P. et al.

Olink Explore 3072/384NephrologyPathophysiologyPlasma

3635 publications